๐ฐ $DOS /USDT
๐ผ LONG
โณ๏ธ ENTRY (Use DCA STRATEGY) : 0.255 , 0.25, 0.244
๐ฏ TARGETS - 0.263 , 0.27, 0.28 , 0.295 , 0.32 , 0.4 , 0.5 , 1
๐๏ธ LEVERAGE -ย cross 10x
๐ด STOPLOSS - 0.237
$CRMD.US $BMNR ๐๐ค๐ฅ 10 ๐๐ฉ๐ค๐๐ ๐จ ๐๐ฎ 3-๐๐๐๐ง ๐๐๐ซ๐๐ฃ๐ช๐ ๐๐ง๐ค๐ฌ๐ฉ๐ ๐๐๐ฉ๐ ๐๐พ ๐ผ๐๐ค๐ซ๐ $100๐
-
CorMedix leads with revenue up 2,231% over three years, followed by vTv Therapeutics at +1,500% and TON Strategy at +1,233%. Six of the ten are biotech companies - and the list says as much about where each started as where it got to.
Growth of 1,500% on $36.8M of revenue is a different achievement than 484% on $9.9B, and both sit in the same table. What separates them is what ...
Setup longย $BTC
entry : 61,900- 63,900
sl : 60,900
TP1 : 65,500
TP2 : 66,772
TP3 : 69,400
Regulatory tailwinds : The SECโs proposed Regulation Crypto Assets and the Treasuryโs GENIUS Act aim to foster domestic innovation and strengthen the USDโs crypto dominance.
Tradeย $BTC ย here ๐
{future}(BTCUSDT)